Cargando…

Understanding the Natural Progression of Spina Bifida: Prospective Study

BACKGROUND: Spina bifida (SB) is monitored through birth defects surveillance across the United States and in most developed countries. Although much is known about the management of SB and its many comorbid conditions in affected individuals, there are few systematic, longitudinal studies on popula...

Descripción completa

Detalles Bibliográficos
Autores principales: Thibadeau, Judy, Reeder, Matthew R, Andrews, Jennifer, Ong, Katherine, Feldkamp, Marcia L, Rice, Sydney, Alriksson-Schmidt, Ann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5620456/
https://www.ncbi.nlm.nih.gov/pubmed/28912114
http://dx.doi.org/10.2196/resprot.7739
_version_ 1783267590914703360
author Thibadeau, Judy
Reeder, Matthew R
Andrews, Jennifer
Ong, Katherine
Feldkamp, Marcia L
Rice, Sydney
Alriksson-Schmidt, Ann
author_facet Thibadeau, Judy
Reeder, Matthew R
Andrews, Jennifer
Ong, Katherine
Feldkamp, Marcia L
Rice, Sydney
Alriksson-Schmidt, Ann
author_sort Thibadeau, Judy
collection PubMed
description BACKGROUND: Spina bifida (SB) is monitored through birth defects surveillance across the United States and in most developed countries. Although much is known about the management of SB and its many comorbid conditions in affected individuals, there are few systematic, longitudinal studies on population-based cohorts of children or adults. The natural history of SB across the life course of persons with this condition is not well documented. Earlier identification of comorbidities and secondary conditions could allow for earlier intervention that might enhance the developmental trajectory for children with SB. OBJECTIVE: The purpose of this project was to assess the development, health, and condition progression by prospectively studying children who were born with SB in Arizona and Utah. In addition, the methodology used to collect the data would be evaluated and revised as appropriate. METHODS: Parents of children with SB aged 3-6 years were eligible to participate in the study, in English or Spanish. The actual recruitment process was closely documented. Data on medical history were collected from medical records; family functioning, child behaviors, self-care, mobility and functioning, and health and well-being from parent reports; and neuropsychological data from testing of the child. RESULTS: In total, 152 individuals with SB were identified as eligible and their parents were contacted by site personnel for enrollment in the study. Of those, 45 (29.6%) declined to participate and 6 (3.9%) consented but did not follow through. Among 101 parents willing to participate, 81 (80.2%) completed the full protocol and 20 (19.8%) completed the partial protocol. Utah enrolled 72.3% (73/101) of participants, predominately non-Hispanic (60/73, 82%) and male (47/73, 64%). Arizona enrolled 56% (28/50) of participants they had permission to contact, predominately Hispanic (18/28, 64%) and male (16/28, 57%). CONCLUSIONS: We observed variance by site for recruitment, due to differences in identification and ascertainment of eligible cases and the required institutional review board processes. Restriction in recruitment and the proportion of minorities likely impacted participation rates in Arizona more than Utah.
format Online
Article
Text
id pubmed-5620456
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher JMIR Publications
record_format MEDLINE/PubMed
spelling pubmed-56204562017-10-05 Understanding the Natural Progression of Spina Bifida: Prospective Study Thibadeau, Judy Reeder, Matthew R Andrews, Jennifer Ong, Katherine Feldkamp, Marcia L Rice, Sydney Alriksson-Schmidt, Ann JMIR Res Protoc Protocol BACKGROUND: Spina bifida (SB) is monitored through birth defects surveillance across the United States and in most developed countries. Although much is known about the management of SB and its many comorbid conditions in affected individuals, there are few systematic, longitudinal studies on population-based cohorts of children or adults. The natural history of SB across the life course of persons with this condition is not well documented. Earlier identification of comorbidities and secondary conditions could allow for earlier intervention that might enhance the developmental trajectory for children with SB. OBJECTIVE: The purpose of this project was to assess the development, health, and condition progression by prospectively studying children who were born with SB in Arizona and Utah. In addition, the methodology used to collect the data would be evaluated and revised as appropriate. METHODS: Parents of children with SB aged 3-6 years were eligible to participate in the study, in English or Spanish. The actual recruitment process was closely documented. Data on medical history were collected from medical records; family functioning, child behaviors, self-care, mobility and functioning, and health and well-being from parent reports; and neuropsychological data from testing of the child. RESULTS: In total, 152 individuals with SB were identified as eligible and their parents were contacted by site personnel for enrollment in the study. Of those, 45 (29.6%) declined to participate and 6 (3.9%) consented but did not follow through. Among 101 parents willing to participate, 81 (80.2%) completed the full protocol and 20 (19.8%) completed the partial protocol. Utah enrolled 72.3% (73/101) of participants, predominately non-Hispanic (60/73, 82%) and male (47/73, 64%). Arizona enrolled 56% (28/50) of participants they had permission to contact, predominately Hispanic (18/28, 64%) and male (16/28, 57%). CONCLUSIONS: We observed variance by site for recruitment, due to differences in identification and ascertainment of eligible cases and the required institutional review board processes. Restriction in recruitment and the proportion of minorities likely impacted participation rates in Arizona more than Utah. JMIR Publications 2017-09-14 /pmc/articles/PMC5620456/ /pubmed/28912114 http://dx.doi.org/10.2196/resprot.7739 Text en ©Judy Thibadeau, Matthew R Reeder, Jennifer Andrews, Katherine Ong, Marcia L Feldkamp, Sydney Rice, Ann Alriksson-Schmidt. Originally published in JMIR Research Protocols (http://www.researchprotocols.org), 14.09.2017. https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Research Protocols, is properly cited. The complete bibliographic information, a link to the original publication on http://www.researchprotocols.org, as well as this copyright and license information must be included.
spellingShingle Protocol
Thibadeau, Judy
Reeder, Matthew R
Andrews, Jennifer
Ong, Katherine
Feldkamp, Marcia L
Rice, Sydney
Alriksson-Schmidt, Ann
Understanding the Natural Progression of Spina Bifida: Prospective Study
title Understanding the Natural Progression of Spina Bifida: Prospective Study
title_full Understanding the Natural Progression of Spina Bifida: Prospective Study
title_fullStr Understanding the Natural Progression of Spina Bifida: Prospective Study
title_full_unstemmed Understanding the Natural Progression of Spina Bifida: Prospective Study
title_short Understanding the Natural Progression of Spina Bifida: Prospective Study
title_sort understanding the natural progression of spina bifida: prospective study
topic Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5620456/
https://www.ncbi.nlm.nih.gov/pubmed/28912114
http://dx.doi.org/10.2196/resprot.7739
work_keys_str_mv AT thibadeaujudy understandingthenaturalprogressionofspinabifidaprospectivestudy
AT reedermatthewr understandingthenaturalprogressionofspinabifidaprospectivestudy
AT andrewsjennifer understandingthenaturalprogressionofspinabifidaprospectivestudy
AT ongkatherine understandingthenaturalprogressionofspinabifidaprospectivestudy
AT feldkampmarcial understandingthenaturalprogressionofspinabifidaprospectivestudy
AT ricesydney understandingthenaturalprogressionofspinabifidaprospectivestudy
AT alrikssonschmidtann understandingthenaturalprogressionofspinabifidaprospectivestudy